Records are supplied by study sponsors and investigators. A registry listing is not an endorsement or a guarantee of safety, availability or eligibility.
WCR feed checked: Nov 11, 2026.
RecruitingNCT07867080
Diabetic Macular Edema (DME)
Phase 318 years - Not specifiedScottsdale, Arizona, United States +84 A Phase 3, Randomized, Double-Masked, Active-Controlled Trial to Evaluate the Safety, Efficacy, and Durability of a Single Intravitreal Injection of 4D-150 versus Aflibercept in Adults with Diabetic Macular Edema (4SIGHT)
RecruitingNCT06824467
Ovarian Cancer · Fallopian Tube Cancer · Primary Peritoneal Cancer
Phase 318 years - Not specifiedBirmingham, Alabama, United States +175 The main goals of this study are to learn about the safety of sacituzumab tirumotecan with bevacizumab and if people tolerate it; and if people who take sacituzumab tirumotecan with or without bevacizumab live longer without the cancer getting worse …
By invitationNCT07842302
Multiple Sclerosis
Not applicable18 years - Not specifiedMadrid, Madrid, Spain Multiple Sclerosis (MS) is a chronic neurological disease impacting 2.8 million individuals globally, with fatigue being its most debilitating symptom, reported by 75% of patients. Despite its prevalence, the pathophysiology of MS-related fatigue rem…
Not yet recruitingNCT07469501
Opioid Use Disorder · Fentanyl
Phase 418 years - Not specifiedSan Francisco, California, United States The goal of this pragmatic randomized controlled trial is to compare treatment outcomes of two strategies for initiating buprenorphine treatment (low-dose initiation and direct-to-inject) in adults with opioid use disorder (OUD) who use fentanyl. Thi…
RecruitingNCT07549061
NSCLC (Advanced Non-small Cell Lung Cancer)
Phase 218 years - Not specifiedShanghai, Shanghai Municipality, China To explore the efficacy and safety of vebreltinib plus platinum-doublet chemotherapy as first-line therapy in patients with driver mutation-negative, MET-overexpressing, PD-L1 TPS \< 50%, locally advanced or metastatic NSCLC .
RecruitingNCT06942559
Obsessive Compulsive Disorder (OCD) · Treatment Resistant Obsessive Compulsive Disorder
Not applicable18 years - 65 yearsToronto, Ontario, Canada This trial aims to obtain initial evidence about the clinical efficacy and modulation of neurophysiological markers in obsessive compulsive disorder (OCD) using personalized (i.e., electroencephalography (EEG)-triggered) repetitive transcranial magne…
RecruitingNCT07728903
Watching a Comedy Video
Not applicable18 years - Not specifiedMersin, Turkey, Turkey (Türkiye) +1 This study aims to determine the effects of watching a comedy video on anxiety, pain, procedural readiness, and uroflowmetric parameters in patients undergoing urodynamic testing. Data will be collected using the Descriptive Characteristics Form, Sta…
RecruitingNCT07680790
Non-Small Cell Lung Cancer
Phase 318 years - Not specifiedBeverly Hills, California, United States +179 The purpose of this study is to evaluate izalontamab brengitecan (iza-bren) combined with osimertinib in participants with previously untreated, locally advanced or metastatic EGFR-mutant NSCLC, compared to osimertinib alone or osimertinib combined w…
RecruitingNCT04839705
Wide Neck Bifurcation Intracranial Aneurysms
Not applicable18 years - Not specifiedHollywood, Florida, United States +24 A prospective, multicenter, single arm, interventional study. The target patient population for this study are adult subjects with WNBAs of the anterior and posterior intracranial circulation. The primary effectiveness outcome of the study is adequat…
CompletedNCT06800911
Obesity
Observational18 years - 65 yearsOggebbio, Verbania, Italy The study aims to investigate the presence of metacognitive beliefs, emotional regulation, and emotional eating in obese patients and their possible relationships.
CompletedNCT06877234
Essential Hypertension
Not applicable18 years - 65 yearsGuangzhou, Guangdong, China This study is a prospective and exploratory clinical study, enrolling patients with essential hypertension. This study is planned to be conducted in 2 research institutions in China, and a total of 6 subjects are planned to be included. After the sub…
RecruitingNCT02438904
Blood And Marrow Transplantation
Not applicableNot specified - Not specifiedHouston, Texas, United States Objectives: Primary Objective To provide compassionate access to the Miltenyi device for CD34+ cell infusions to patients who experience poor graft function after stem cell transplantation (SCT).
Retrieved from ClinicalTrials.gov: Nov 11, 2026. Overall study status may differ from a particular location’s status.
